Table 3.
Types of ageratum extract formulated in pharmaceutical dosage form, the respective active ingredients, and the protein target being studied.
| Extract | Formulation | Active ingredient | Protein target | |
|---|---|---|---|---|
| Part | Solvent | |||
| Root | Ethanol | Ointment | Alkaloids | Ornithine delta-aminotransferase |
|
| ||||
| Aerial part | Methanol | Emulsifiable | Precocene I | Cyclooxygenase-2, MMP-9 |
| Concentrate | Precocene II | |||
|
| ||||
| Aerial part | Dichloromethane | Emulsifiable | Precocene I | Cyclooxygenase-2, MMP-9 |
| Concentrate | Precocene II | |||
|
| ||||
| Aerial part | Hexane | Emulsifiable concentrate | Precocene I | Cyclooxygenase-2, MMP-9 |
| Precocene II | ||||
|
| ||||
| Leaves | Ethanol | Gel | Alkaloids, flavonoids | Ornithine delta-aminotransferase, MMP-9 |
|
| ||||
| Aerial part | Ethanol | Nanoemulgel | Alkaloids, flavonoids | Ornithine delta-aminotransferase, MMP-9 |